Unexpectedly but reasonably, we found that the severe gemcitabine chemoresistance in CCA, especially in the HyPer-low subpopulation of CCA cells, was due to the relatively high expression of MTHFD1, the key enzyme in folate metabolism. The gene discussed is MTHFD1; the disease is cholangiocarcinoma.